|
UBQLN2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.11109999999071E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.246300E-04 |
| Normal-vs-Stage2 |
4.300900E-03 |
| Normal-vs-Stage3 |
1.4371000000013E-06 |
| Normal-vs-Stage4 |
1.99144999999401E-05 |
| Stage1-vs-Stage2 |
4.837600E-01 |
| Stage1-vs-Stage3 |
8.116700E-03 |
| Stage1-vs-Stage4 |
2.894400E-02 |
| Stage2-vs-Stage3 |
2.268600E-01 |
| Stage2-vs-Stage4 |
3.567000E-01 |
| Stage3-vs-Stage4 |
7.016400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.5724999999951E-05 |
| Normal-vs-AfricanAmerican |
3.93149999999842E-05 |
| Normal-vs-Asian |
1.720600E-01 |
| Caucasian-vs-AfricanAmerican |
2.249400E-01 |
| Caucasian-vs-Asian |
9.343000E-01 |
| AfricanAmerican-vs-Asian |
5.739800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.52345999999692E-05 |
| Normal-vs-Female |
8.429700E-04 |
| Male-vs-Female |
1.151420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.376600E-03 |
| Normal-vs-Age(41-60Yrs) |
7.354700E-04 |
| Normal-vs-Age(61-80Yrs) |
1.95795999999859E-05 |
| Normal-vs-Age(81-100Yrs) |
3.978900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.418200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.032000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.174200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.856200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.319370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.572800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.748800E-01 |
| Normal-vs-Grade 2 |
3.162000E-03 |
| Normal-vs-Grade 3 |
1.70899999996088E-06 |
| Normal-vs-Grade 4 |
7.29359999951384E-07 |
| Grade 1-vs-Grade 2 |
1.072410E-01 |
| Grade 1-vs-Grade 3 |
1.369770E-02 |
| Grade 1-vs-Grade 4 |
3.364100E-03 |
| Grade 2-vs-Grade 3 |
7.584100E-03 |
| Grade 2-vs-Grade 4 |
2.642400E-03 |
| Grade 3-vs-Grade 4 |
3.165800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.103400E-03 |
| Normal-vs-ccB subtype |
1.376610E-04 |
| ccA subtype-vs-ccB subtype |
6.623800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.189500E-04 |
| Normal-vs-N1 |
1.139920E-02 |
| N0-vs-N1 |
5.559600E-01 |
|
|
